Total Funding
82
55
Total FundingSeed raised
Growth Score 82 in past quarter
-5 pts
Heat Score 55 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
274106
StaphOff Biotech develops medical products that prevent resistant staphylococcal infections.
- Aquiles Mendoza: CFO
- Naomi Balaban: Founder
About the Company
StaphOff Biotech, Inc., a pharmaceutical company, develops medical products that prevent or stop resistant staphylococcal infections. The company is involved in developing CEN-101, a molecule that could be used as a topical drug, as a locally injectable drug, and as an intravenously administered drug, as well as in a device coating solution and in
a sterile-lock to prevent or treat staphylococcal infections. The company was incorporated in 2011 and is based in Hopkinton, Massachusetts.
Women Founded
Women Led
